Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Cell Line, Tumor
Humans
6
Proto-Oncogene Proteins c-akt
6
article
6
controlled study
6
human
6
human cell
6
phosphatidylinositol 3 kinase
protein kinase B
6
protein phosphorylation
signal transduction
6
Cell Hypoxia
4
Cell Line
4
Cell Survival
4
Eukaryotic Initiation Factor-2
4
HeLa Cells
4
PERK protein
4
activating transcription factor 6
4
cell death
4
cell fate
4
cell protein
4
eIF-2 Kinase
4
hypoxia
4
initiation factor 2alpha
4
inositol requiring protein 1
4
physiological process
4
protein protein interaction
4
protein targeting
4
protein unfolding
4
unclassified drug
4
-
1Modulation of the Akt Pathway Reveals a Novel Link with PERK/eIF2α, which Is Relevant during Hypoxiapor Blaustein Kappelmacher, Matias, Grande, Alicia Viviana, Risso, Guillermo Javier, Srebrow, Anabella, Colman Lerner, Alejandro ArielMaterias: “...initiation factor 2alpha...”
Publicado 2013
-
2Modulation of the Akt Pathway Reveals a Novel Link with PERK/eIF2α, which Is Relevant during Hypoxiapor Blaustein, M., Pérez-Munizaga, D., Sánchez, M.A., Urrutia, C., Grande, A., Risso, G., Srebrow, A., Alfaro, J., Colman-Lerner, A.Materias: “...initiation factor 2alpha...”
Publicado 2013
Artículo publishedVersion -
3Modulation of the Akt Pathway Reveals a Novel Link with PERK/eIF2α, which Is Relevant during Hypoxiapor Blaustein, M., Pérez-Munizaga, D., Sánchez, M.A., Urrutia, C., Grande, A., Risso, G., Srebrow, A., Alfaro, J., Colman-Lerner, A.Materias: “...initiation factor 2alpha...”
Publicado 2013
Artículo publishedVersion -
4Modulation of the Akt Pathway Reveals a Novel Link with PERK/eIF2α, which Is Relevant during Hypoxiapor Blaustein, M., Pérez-Munizaga, D., Sánchez, M.A., Urrutia, C., Grande, A., Risso, G., Srebrow, A., Alfaro, J., Colman-Lerner, A.Materias: “...initiation factor 2alpha...”
JOUR -
5Materias: “...initiation factor 4E...”
-
6por Pérez-Pérez, A., Gambino, Y., Maymó, J., Goberna, R., Fabiani, F., Varone, C., Sánchez-Margalet, V.Materias: “...initiation factor 4E...”
JOUR